Estrella Immunopharma, Inc. Stock Analysis & AI Score
Estrella Immunopharma, Inc. (ESLA) has an ST Score of 37.6 (C), driven by its Valuation (B+) and held back by its Momentum (D-). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Estrella Immunopharma, Inc. (ESLA) has an ST Score of 37.6 (C), driven by its Valuation (B+) and held back by its Momentum (D-). Analysts rate it Buy.
- Strongest
- ValuationB+
- Weakest
- MomentumD-
All factor grades
- ValuationB+
- ProfitabilityB
- Financial StrengthC-
- GrowthC-
- MomentumD-
- Piotroski2/9
Contact
ESLA stock: frequently asked questions
What is ESLA's ST Score?
Estrella Immunopharma, Inc. (ESLA) has an ST Score of 37.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ESLA a buy, hold, or sell?
Analysts rate ESLA a Buy. Our ST Score grades it C (37.6/100). The ST Score is a data-driven signal, not a recommendation.
What are ESLA's factor grades?
Valuation B+, Profitability B, Financial Strength C-, Momentum D-, Growth C-.
What is ESLA's valuation grade?
Estrella Immunopharma, Inc. (ESLA) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ESLA's growth grade?
Estrella Immunopharma, Inc. (ESLA) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ESLA's profitability grade?
Estrella Immunopharma, Inc. (ESLA) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ESLA's financial strength grade?
Estrella Immunopharma, Inc. (ESLA) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is ESLA's Piotroski score?
Estrella Immunopharma, Inc. (ESLA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.